Du, Y., Rosner, B.M., Knopf, H., Schwarz, S., Dören, M., Scheidt-Nave, C. Hormonal contraceptive use among adolescent girls in Germany in relation to health behavior and biological cardiovascular risk factors (2011 
Introduction
Hormonal contraceptives (HCs) have been recommended for the prevention of unintended pregnancies among adolescents in Germany because they are considered relatively safe as compared with other methods of contraception [1] . In addition, the use of HCs among adolescents may have positive effects on certain hormonal disorders such as dysmenorrhea, irregular menstrual cycles, and acne [2] . However, HCs have also been associated with adverse health effects. In epidemiological studies conducted among adult women, cardiovascular health risks, such as venous thrombosis, ischemic and hemorrhagic stroke, and myocardial infarction have been shown to be higher among users of HCs than among nonusers [3] [4] [5] [6] [7] [8] . Consequently, the estrogen content of HCs has been gradually reduced from 150 µg to 35, and the progestin component has been modified. HCs available on the market currently are considered to have fewer adverse health effects because of this lower estrogen content and altered progestin; however, some studies with more recently introduced preparations do not support this view [9, 10] .
Evidence on health risks of HC use among adolescents is scarce. Events such as venous thrombosis, stroke, and myocardial infarction occur rarely in adolescents, thus, hard endpoint studies would require extended follow-up far into adulthood. Previous epidemiological studies on HCs and cardiovascular risk in adolescents focused on behavioral risk factors relevant to cardiovascular risk or surrogate endpoints, such as blood pressure and serum lipids [11] [12] [13] [14] [15] [16] .
These studies were conducted in the 1980s or 1990s, and few studies were populationbased.
We present recent and nationally representative data on the association between current HC use, health-related behaviors, and main biological cardiovascular risk factors among teenage girls in Germany. We specifically asked: (1) Is there a significant association between HC use and behavioral as well as biological cardiovascular risk factors among adolescent girls in Germany? (2) What is the relative contribution of HC use in models of biological risk factors independent of behavioral cardiovascular risk factors and other covariates?
Methods

Data source and study population
The German Health Interview and Examination Survey for Children and Adolescents aged 0-17 years living in Germany. The design, sampling strategy, and study protocol have been described elsewhere in detail [17] . Briefly, a two-stage random clustered sample of the target population was drawn on the basis of a representative sample of German communities [17] . The study was conducted according to a highly standardized protocol encompassing a medical computer-assisted interview, self-administered questionnaires, and standardized physical examinations including blood pressure measurements and casual venous blood sampling for biochemical tests. The final sample included 17,641 children and adolescents (8, 985 boys, 8,656 girls). The overall response rate was 66.6% (69% in age group 11-13 years; 63% in age group 14-17 years). Nonresponse analysis showed little variation between the age groups and sexes, and no difference was found with respect to health-related variables [17] . The survey was approved by federal data protection officials and by the Charité Universitätsmedizin Berlin medical ethics committee. Written informed consent was obtained before the interview and examination from the children's parents and the children themselves if they were over 14 years of age. This study was restricted to the 2,307 girls aged 13-17 years who participated in the KiGGS. Of them, 22 girls who did not take part in the drug use survey were excluded, resulting in a study population of 2,285 girls available for the present analysis.
Assessment of hormonal contraceptive use
Survey participants were asked in advance to bring prescriptions or original medicine containers to the examination sites. Use of any medication, including prescription drugs and over-the-counter medications, within seven days before the medical examination was assessed using a computer-assisted standardized drug use questionnaire. Details of medication use were documented, such as brand name, condition(s) treated, daily dosage, route of application, and duration of use. Specific ATC (Anatomical Therapeutic Chemical) codes were assigned to all reported medications and WHO ICD-10 codes to the conditions for which the medications were taken. For each medication recorded, a maximum of two conditions could be provided. We identified a total of 445 participants who took medications with ATC-codes G03A (HCs for systemic use, n=428), G03HB01 (combinations of cyproterone acetate (antiandrogen) and estrogens, for treatment of acne and hirsutism, n=15), and G02B (contraceptives for topical use, n=2).
Definition of behavioral cardiovascular risk factors, biological cardiovascular risk factors, and sociodemographic covariates
Behavioral cardiovascular risk factors included cigarette smoking, regular alcohol consumption, physical activity assessed as engagement in sports activities, and overweight status measured as body mass index (BMI) class. Standardized, self-administered questionnaires were used to collect information regarding behavior-related health risks and sociodemographic characteristics. Questionnaires were tailored to specific age groups (e. g., 11-13 years; 14-17 years) to capture health-related information of particular relevance to important developmental stages. Separate questionnaires were offered to the parents and to the children aged 11 years [17] . We used information provided by the girls themselves to define health-related behavior. Girls were classified as current smokers if they answered the question "Do you currently smoke?" with "daily", "several times a week", "once a week", or "occasionally". Regular alcohol consumption was defined as drinking a minimum of one glass of beer, wine, or hard liquor per week. The frequency of physical activity was assessed with the question, "In your leisure time, how often do you engage in physical activity (e.g., when doing sports or riding bicycle) that leads to heavy sweating or being out of breath?" with the answer choices "about every day", "three to five times a week", "about once or twice a week", "about once or twice a month", or "never". For the present analysis, the frequency of physical activity was defined as "often" (three to five times a week or more), "sometimes" (about once or twice a week, or about once or twice a month), and "never". BMI was computed from standardized measures of children's weight and height. Relative body weight was classified as normal, overweight, or underweight according to Kromeyer-Hauschild (overweight: BMI above the age-and sex-specific 90 th percentile; underweight: BMI below the age-and sexspecific 10 th percentile) [18] . In some regression models, we included pubertal stage as selfreported Tanner stage of pubic hair (stage 1: Tanner 1; stage 2: Tanner 2-3; stage 3: Tanner 4-6) and menarche status (yes/no) as additional factors [19] .
Biological cardiovascular risk factors included blood pressure and serum concentrations of total cholesterol, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides, high sensitivity C-reactive protein (hs-CRP), and homocysteine. Analytical methods have been previously described in detail [20] .
Standardized measurements of systolic, diastolic, and mean arterial pressure were obtained using an automated oscillometric blood pressure device. The means of two independent readings for systolic blood pressure (SBP) and diastolic blood pressure (DBP) were used in the present analysis.
Because associations between HC use and certain sociodemographic factors, such as residence in East or West Germany, family social status, and family immigration background, were conceivable, these covariates were included in regression models. The 10 federal states of the Federal Republic of Germany before reunification were defined as West Germany, the five new federal states covering the region of the former German Democratic
Republic and the federal state of Berlin were defined as East Germany. Family social status score was computed integrating information obtained from the parents' questionnaire on both parents' educational level and professional status as well as total family income [17, 21] .
Family immigration status was assessed on the basis of the information collected on nationality, country of birth, and year of immigration of both parents [17] . Girls were classified as having an immigration background if either they themselves had immigrated from another country and at least one parent was not born in Germany, or if both parents were immigrants or not of German nationality.
Statistical analysis
Multivariable logistic regression was applied to identify independent determinants of HC use;
results are expressed as adjusted odds ratios and 95% confidence intervals. [17] . The complex sample method was used to account for clustering due to the two-stage sampling procedure [17] .
Results
Overall prevalence, indications, and patterns of current hormonal contraceptive use
Overall, 19.6% among girls aged 13-17 years were currently using HCs ( 
Sociodemographic determinants of current hormonal contraceptive use
The prevalence of HC use increased continuously with age, ranging from 0.2% among 13-year-olds to 45.6% among 17-year-olds (Table 1) . HC use was significantly and inversely related to residence in West versus East Germany and to immigration background (Table 1) .
No significant association was found between HC use and family social status (Table 1) .
Results persisted in multivariable logistic regression of HC use on sociodemographic factors (data not shown). Considering individual components of social status, for example, parental education levels or household income, in separate models also did not change the results
(data not shown).
Association between hormonal contraceptive use and modifiable health-related behavioral risk factors
As compared with nonusers, HC users were significantly more likely to be current smokers (56% vs. 20%), to consume alcohol on a regular basis (38% vs. 14%), and to report not to be involved in any sports activity (24% vs. 15%) ( Table 1) . Age-stratified analysis showed that group differences between HC users and nonusers declined with increasing age (Figure 1 ).
Among girls aged <16 years, current HC use was significantly related to all three behaviorrelated cardiovascular risk factors. Significant differences between HC users and nonusers were reduced to current smoking and alcohol use among 16-year-old girls and to current smoking alone among 17-year-old girls ( Figure 1 ). Consistently, HC users and nonusers did not significantly differ with respect to overweight status ( Figure 1 ). HC users were more likely than nonusers to have combinations of behavioral cardiovascular risk factors (cigarette smoking, alcohol consumption, inactivity, and being overweight). Overall, 80% of HC users had at least one out of the four selected risk factors as opposed to 47% of nonusers. A total of 25.2% of HC users had two, and 14.5% had three or four of the risk factors considered, in contrast to 13.5% and 3.1%, respectively, among non-users (data not shown in Figure 1 ).
Associations between individual behavioral cardiovascular risk factors and HC use were reduced but not fully explained in multivariable logistic regression analyses, adjusting for sociodemographic variables (Table 2) . Results did not materially change when 13-and 14-year-old girls were excluded from the regression model (e.g., OR for smoking was then 3.10 (2.45-3.93)).
Independent associations between current HC use and biological cardiovascular risk factors
Adjusting for behavioral cardiovascular risk factors, sociodemographic covariates, and pubertal stage, HC users had significantly higher mean SBP and DBP, and higher mean serum concentrations of total cholesterol, HDL-C, LDL-C, triglycerides, and hs-CRP as compared with nonusers (Table 3) . No statistically significant association was observed between HC use and serum homocysteine. Absolute differences between HC users and nonusers increased with extended duration of HC use (≥ 1 year vs. < 1 year), although group mean differences between short term (<1 year) and longer term (≥ 1 year) users did not reach statistical significance (p values not shown in Table 3 ). Mean levels of biological cardiovascular risk factors did not consistently differ in relation to estrogen content or progestin generation with the exception of mean serum HDL-C concentrations. These were significantly higher among HC users of preparations with higher estrogen content (30 or >30 g vs. 20 g) as well as among users of preparations containing third-and fourth-generation progestins compared with users of preparations containing second-generation progestins (data not shown).
In general linear models including sociodemographic variables, behavioral cardiovascular risk factors, and pubertal stage, HC use explained a small to moderate additional proportion of the population variance of biological cardiovascular risk factors (Table 4) . Relative contributions of HC use ranged between <1% in models with SBP or DBP as dependent variables and 12.3% in models with hs-CRP as the dependent variable (Table 4) . We observed no interaction between HC use and smoking or other behavioral cardiovascular risk factors (data not shown).
Discussion
Overall, 19.6% of 13-17-year-old girls in Germany were currently using HCs. This prevalence estimate is consistent with results obtained from a previous interview survey conducted among 14-17-year-old girls in Germany, despite methodological differences in study design [22] . Our results are also similar to prevalence estimates reported by other western European countries [11, 23, 24] .
In contrast to a previous study among Finnish teenagers [25] Germany have an Islamic background, thus, cultural and religious influences are likely to restrict the proportion of sexually active girls and the demand for HCs. As observed among teenagers in the present study, HC use among adult women was previously reported to be significantly higher in eastern German federal states than in western federal states [26, 27] , possibly because of easier access to this contraceptive method in the former German Democratic Republic [27] . Although differences in health and health-related behavior between children and adolescents living in former East and West Germany have almost disappeared within the 20 years since reunification [28] , the mother's preference may conceivably affect the daughter's choice of contraception method.
An association between HC use and unhealthy lifestyle, in particular current cigarette smoking, was found in our study as well as in others [11] [12] [13] [14] 29] . Clustering of behavioral cardiovascular risk factors among adolescents has been previously observed to be associated with an adverse biological cardiovascular risk profile [13] . Previous studies conducted among adolescents reported an association of HC use and elevated SBP, DBP, serum total cholesterol and LDL-C [11, [13] [14] [15] [16] . Studies that were conducted in the 1970s and 1980s found decreased HDL-C levels among HC users as compared with nonusers [16, 30] .
In contrast, in the present study, HDL-C levels were higher among HC users than nonusers, The main strength of the present study is that HC use could be investigated in a nationally representative sample of 13 -17-year-old girls in Germany. Recall bias with respect to medication use was minimized because questions referred to the 7 days before the interview rather than a longer period. In addition, study participants were encouraged to bring their prescriptions or medication packages to the medical interview, which increased the quality of medication use data. There are limitations to our study. Because of the cross-sectional study design, neither the clinical relevance nor the causality of the observed association between HC use and biological cardiovascular risk factors can be established. Also, we cannot exclude misclassification bias caused by underreporting. Although some study participants may have chosen not to admit to HC use during the interview, the number is likely to be small. Ethnicity of the study participants could be a confounding factor because biological cardiovascular risk factors are well known to differ by ethnicity. The present study included a representative proportion of adolescents with immigration background. However, this group was largely dominated by study participants with a Turkish background, whereas the number of black or Asian children was very small. Thus, the present study did not permit to differentiate between ethnically distinct subgroups.
Among healthy girls, small increments in cardiovascular risk are likely to be outweighed by the benefits of HC use, mainly protection from teenage pregnancy. However, the strong correlation between HC use and avoidable risk behaviors, in particular cigarette smoking, is of public health concern. Because HCs are only available on prescription, physicians prescribing them should take the opportunity to systematically assess the occurrence of modifiable behavior-related risk factors and provide evidence-based counseling tailored to the needs of the individual teenage patient.
29. Results obtained from general linear models. 
